Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issam Zineh

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Pharmacogenetics and Genomics|December 4, 2010
Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patientsMaximilian T Lobmeyer, Liewei Wang, Issam Zineh, et al.
Molecular Diagnosis & Therapy|November 28, 2008
CXCL5 gene polymorphism association with diabetes mellitusShirin Hasani Ranjbar, Parvin Amiri, Issam Zineh, et al.
JAMA Network Open|January 23, 2024
Intranasal Naloxone Repeat Dosing Strategies and Fentanyl Overdose: A Simulation-Based Randomized Clinical TrialDavid G Strauss, Zhihua Li, Anik Chaturbedi, et al.
Archives of Internal Medicine|May 13, 2009
Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart ProjectMartha Gulati, Rhonda M Cooper-DeHoff, Candace McClure, et al.
Clinical Pharmacology and Therapeutics|October 25, 2022
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (I) A Randomized Trial with PCSK9 InhibitorsMorasa Sheikhy, Sarah J Schrieber, Qin Sun, et al.
Journal of Clinical Pharmacology|January 23, 2020
Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and VomitingJeremiah D Momper, M Tobias Heinrichs, Kevin Krudys, et al.
Clinical Pharmacology and Therapeutics|February 24, 2018
Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a DiseaseRobert N Schuck, Janet Woodcock, Issam Zineh, et al.
Pharmacogenomics|December 15, 2010
Learning from product labels and label changes: how to build pharmacogenomics into drug-development programsLinda C Surh, Michael A Pacanowski, Susanne B Haga, et al.
Clinical Cardiology|May 20, 2009
Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome EvaluationChristopher B Arant, Timothy R Wessel, Paul M Ridker, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 6, 2014
Pharmacokinetic assessment in patients receiving continuous RRT: perspectives from the Kidney Health InitiativeThomas D Nolin, George R Aronoff, William H Fissell, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Pharmacogenetics and Genomics|December 4, 2010
Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patientsMaximilian T Lobmeyer, Liewei Wang, Issam Zineh, et al.
Molecular Diagnosis & Therapy|November 28, 2008
CXCL5 gene polymorphism association with diabetes mellitusShirin Hasani Ranjbar, Parvin Amiri, Issam Zineh, et al.
JAMA Network Open|January 23, 2024
Intranasal Naloxone Repeat Dosing Strategies and Fentanyl Overdose: A Simulation-Based Randomized Clinical TrialDavid G Strauss, Zhihua Li, Anik Chaturbedi, et al.
Archives of Internal Medicine|May 13, 2009
Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart ProjectMartha Gulati, Rhonda M Cooper-DeHoff, Candace McClure, et al.
Clinical Pharmacology and Therapeutics|October 25, 2022
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (I) A Randomized Trial with PCSK9 InhibitorsMorasa Sheikhy, Sarah J Schrieber, Qin Sun, et al.
Journal of Clinical Pharmacology|January 23, 2020
Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and VomitingJeremiah D Momper, M Tobias Heinrichs, Kevin Krudys, et al.
Clinical Pharmacology and Therapeutics|February 24, 2018
Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a DiseaseRobert N Schuck, Janet Woodcock, Issam Zineh, et al.
Pharmacogenomics|December 15, 2010
Learning from product labels and label changes: how to build pharmacogenomics into drug-development programsLinda C Surh, Michael A Pacanowski, Susanne B Haga, et al.
Clinical Cardiology|May 20, 2009
Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome EvaluationChristopher B Arant, Timothy R Wessel, Paul M Ridker, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 6, 2014
Pharmacokinetic assessment in patients receiving continuous RRT: perspectives from the Kidney Health InitiativeThomas D Nolin, George R Aronoff, William H Fissell, et al.
Pageof 13